Reenie McCarthy

Reenie McCarthy

Company: Stealth Biotherapeutics

Job title: Chief Executive Officer


Mitochondria as a Target for Ophthalmic Disease 9:00 am

Examining mitochondrial dysfunction as a key pathology in dry age-related macular degeneration, glaucoma, diabetic retinopathy and Fuch’s corneal endothelial dystrophy Presenting preclinical data demonstrating elamipretide’s effect in models of ophthalmic disease Showcasing clinical data showing that degree of baseline mitochondrial function may predict therapeutic response in patients with dry AMD Demonstrating clinical data which shows…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.